Cohance Lifesciences Ltd (COHANCE) Financials - Quarterly Results, Profit & Loss, Balance Sheet, Cash Flow Cohance Lifesciences Ltd reported sales of ₹422 Cr, operating profit of ₹1 Cr (OPM 0.3%) and net profit of ₹-45 Cr for the quarter ended Jun 2026. Figures in ₹ crore, consolidated where available.
COHANCE quarterly results (₹ Cr) Metric Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sales 604 676 840 549 556 545 619 422 Expenses 398 439 611 437 435 449 520 421 Operating Profit 205 237 229 112 121 95 99 1 OPM 34% 35% 27% 20% 22% 18% 16% 0.3% Other Income 16 22 -4 6 16 1 -18 12 Interest 10 11 10 10 9 9 9 7 Depreciation 38 44 54 45 44 47 51 50 Profit before tax 174 205 161 63 84 41 20 -43 Tax 21% 25% 27% 26% 21% 29% 58% 5% Net Profit 138 153 117 46 66 29 8 -45 EPS in Rs 5.44 6.01 4.73 1.28 1.94 0.96 0.51 -0.63
COHANCE profit & loss, annual (₹ Cr) Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM Sales 1,320 1,340 1,051 1,198 2,269 2,142 Expenses 738 766 645 822 1,842 1,825 Operating Profit 582 574 406 375 427 316 OPM 44% 43% 39% 31% 19% 15% Other Income 133 46 62 58 5 11 Interest 9 13 7 12 37 34 Depreciation 39 48 55 77 187 192 Profit before tax 668 560 406 344 207 101 Tax 32% 27% 26% 23% 27% - Net Profit 454 411 300 265 150 59 EPS in Rs 17.83 16.16 11.8 10.52 4.68 2.78 Dividend Payout 28% 37% 0% 0% 0% -
COHANCE balance sheet (₹ Cr) Metric Mar 2023 Mar 2024 Mar 2025 Sep 2025 Mar 2026 Equity Capital 25 25 25 - 38 Reserves 1,710 2,025 1,671 - 3,873 Borrowings 70 65 279 - 400 Other Liabilities 160 138 1,056 - 1,418 Total Liabilities 1,966 2,254 3,031 - 5,730 Fixed Assets 663 670 1,713 - 3,373 CWIP 165 179 256 - 173 Investments 536 904 337 - 529 Other Assets 601 501 725 - 1,655 Total Assets 1,966 2,254 3,031 - 5,730
COHANCE cash flows (₹ Cr) Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Cash from Operating Activity 330 457 358 288 368 Cash from Investing Activity -136 -195 -362 -253 -255 Cash from Financing Activity -156 -242 -14 3 -165 Net Cash Flow 37 20 -18 38 -51 Free Cash Flow 255 171 307 132 169 CFO/OP 88% 105% 115% 99% 102%
COHANCE ratios Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Debtor Days 65 30 46 87 110 Inventory Days 259 279 268 199 310 Days Payable 97 63 49 96 157 Cash Conversion Cycle 228 247 265 190 263 Working Capital Days 108 99 115 74 175 ROCE 41% 32% 19% 15% 8%